With which diagnosis should a client with Hodgkin's disease and undergoing chemotherapy share a room?

A client with Hodgkin's disease undergoing chemotherapy is typically at risk for infections due to immunosuppression. When considering potential roommates, prioritizing the risk of cross-contamination and infections is essential. Sickle-cell anemia is a blood disorder that does not inherently compromise the immune system in the way that chemotherapy does. Therefore, a client with sickle-cell anemia can be considered a safer roommate as they are less likely to harbor infections that could pose a significant risk to the immunocompromised client.

In contrast, a client with severe allergic reactions may not have an infectious disease, but their episodes could lead to acute situations that might complicate care in a shared room. A client with active tuberculosis poses a significant risk due to the infectious nature of the disease, which can easily be transmitted, especially in close quarters. Lastly, a client who has an upper respiratory infection could carry infections that are particularly dangerous to someone with a weakened immune system due to chemotherapy. Sharing a room with any of these individuals would increase the risk of infection, which is why the client with sickle-cell anemia is the most appropriate choice.